The chemical substance known as "(2S,5S)-1-[4-[5-(4-Fluorophenoxymethyl)tetrahydrofuran-2-yl]-3-butynyl]-1-hydroxyurea" with CAS number 175212-04-1 is characterized by its complex molecular structure, which includes a hydroxyurea moiety and a tetrahydrofuran ring substituted with a fluorophenyl group. This compound exhibits specific stereochemistry, indicated by the (2S,5S) configuration, which is crucial for its biological activity. The presence of the butynyl group suggests potential reactivity and interactions with biological targets. The fluorine atom in the phenoxy group may enhance lipophilicity and influence the compound's pharmacokinetic properties. Overall, this substance is likely to be of interest in medicinal chemistry, particularly in the development of therapeutic agents, due to its unique structural features that may confer specific biological activities. Further studies would be necessary to elucidate its mechanism of action and potential applications in drug development.

(2S,5S)-1-[4-[5-(4-Fluorophenoxymethyl)tetrahydrofuran-2-yl]-3-butynyl]-1-hydroxyurea

175212-04-1: The chemical substance known as "(2S,5S)-1-[4-[5-(4-Fluorophenoxymethyl)tetrahydrofuran-2-yl]-3-butynyl]-1-hydroxyurea" with CAS number 175212-04-1 is characterized by its complex molecular structure, which includes a hydroxyurea moiety and a tetrahydrofuran ring substituted with a fluorophenyl group. This compound exhibits specific stereochemistry, indicated by the (2S,5S) configuration, which is crucial for its biological activity. The presence of the butynyl group suggests potential reactivity and interactions with biological targets. The fluorine atom in the phenoxy group may enhance lipophilicity and influence the compound's pharmacokinetic properties. Overall, this substance is likely to be of interest in medicinal chemistry, particularly in the development of therapeutic agents, due to its unique structural features that may confer specific biological activities. Further studies would be necessary to elucidate its mechanism of action and potential applications in drug development.

<p>CMI977 is a potent inhibitor of 5-Lipoxygenase (5-LO).</p>

CMI977

<p>CMI977 is a potent and selective inhibitor of the human Kv1.3 voltage-gated potassium channel. It has been shown to inhibit the Kv1.3 channel in both recombinant and native preparations, as well as in cells from various tissues. CMI977 has been shown to inhibit proliferation of cancer cells and to induce apoptosis in cell culture. This protein interacts with peptides and antibodies, as well as with other proteins such as ion channels and receptors, which may be used for research purposes.</p>

CAS 175212-04-1

(2S,5S)-1-[4-[5-(4-Fluorophenoxymethyl)tetrahydrofuran-2-yl]-3-butynyl]-1-hydroxyurea

CMI977

Ref: TM-T14986

CMI977

Ref: 3D-AHA21204